{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-018997","form_type":"8-K","ticker":"BBOT","cik":"0001869105","company_name":"BridgeBio Oncology Therapeutics, Inc.","filed_at":"2025-03-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.422699+00:00","generated_at":"2026-05-25T20:46:11.830648+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Helix Acquisition Corp. II to merge with BridgeBio Oncology Therapeutics in $461M deal","bullets":["Equity value of $461M; BBOT stockholders to receive shares of PubCo common stock.","PIPE investments of ~$260M committed, including $75M from Cormorant; minimum $400M cash required at close.","Closing expected after SEC effectiveness, shareholder approvals, and Nasdaq listing; drop-dead date Oct 31, 2025.","Sponsor to forfeit shares if Helix Closing Cash < $400M; non-redemption agreements cover 450,900 Class A shares.","Lock-up on Sponsor and existing Helix investors' shares for one year post-Closing."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-018997","json":"https://secwatch.observer/filing/0001213900-25-018997.json","markdown":"https://secwatch.observer/filing/0001213900-25-018997.md","text":"https://secwatch.observer/filing/0001213900-25-018997.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1869105/000121390025018997/0001213900-25-018997-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1869105/000121390025018997/ea0232544-8k425_helix2.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T20:46:11.830648+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}